Denali Therapeutics Inc (DNLI) — Strategic Asset Allocation Index

Latest as of June 2026: 27.5%

Denali Therapeutics Inc (DNLI) has a Strategic Asset Allocation Index of 27.5% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $229.53 Million) total $229.53 Million, measured against net assets of $835.18 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See DNLI net asset quality index to measure how much of total assets are equity-financed.

SAAI

27.5%
Strategic Assets / Net Assets

Strategic Assets

$229.53 Million
PP&E + LT Investments

PP&E

$-
USD

Net Assets

$835.18 Million
USD

Denali Therapeutics Inc Strategic Asset Allocation Index (2016–2025)

This chart shows how Denali Therapeutics Inc's Strategic Asset Allocation Index has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the index stands at 27.5%, representing strategic assets of $229.53 Million against net assets of $835.18 Million USD. For live market cap and overall valuation, see market value of Denali Therapeutics Inc.

Annual Strategic Asset Allocation Index for Denali Therapeutics Inc (2016–2025)

The table below presents the year-by-year Strategic Asset Allocation Index for Denali Therapeutics Inc from 2016 to 2025, covering 10 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Denali Therapeutics Inc for net asset value and shareholders' equity analysis.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
2025 9.7% $98.32 Million $- $98.32 Million $1.01 Billion ▼ -19.5 pp
2024 29.2% $359.37 Million $- $359.37 Million $1.23 Billion ▲ +29.2 pp
2023 0.0% $0.00 $- $0.00 $1.03 Billion ▼ -7.1 pp
2022 7.1% $74.52 Million $74.52 Million $0.00 $1.04 Billion ▼ -44.3 pp
2021 51.4% $495.06 Million $69.61 Million $425.45 Million $962.29 Million ▲ +45.1 pp
2020 6.4% $73.55 Million $40.85 Million $32.70 Million $1.15 Billion ▼ -24.1 pp
2019 30.5% $120.54 Million $80.66 Million $39.89 Million $394.89 Million ▼ -1.1 pp
2018 31.6% $173.04 Million $25.16 Million $147.88 Million $546.85 Million ▲ +15.3 pp
2017 16.4% $76.17 Million $14.92 Million $61.25 Million $465.80 Million ▼ -18.4 pp
2016 34.7% $88.34 Million $15.26 Million $73.08 Million $254.52 Million
pp = percentage points